The Efficacy and Safety Of The Short Ragweed Sublingual Immunotherapy Tablet MK-3641 Is Similar In Asthmatic and Nonasthmatic Subjects Treated For Allergic Rhinitis With/Without Conjunctivitis (AR/C)

2014 ◽  
Vol 133 (2) ◽  
pp. AB218 ◽  
Author(s):  
Jennifer Maloney ◽  
David I. Bernstein ◽  
Jacques Hébert ◽  
Martha White ◽  
Robert Fisher ◽  
...  
2020 ◽  
Vol 32 (1) ◽  
pp. 86-91
Author(s):  
Wenlong Liu ◽  
Qingxiang Zeng ◽  
Chunhui He ◽  
Rongshan Chen ◽  
Yiquan Tang ◽  
...  

2012 ◽  
Vol 3 (3) ◽  
pp. 177-183 ◽  
Author(s):  
Sue Jean Mun ◽  
Jae Min Shin ◽  
Doo Hee Han ◽  
Jeong-Whun Kim ◽  
Dong-Young Kim ◽  
...  

2013 ◽  
Vol 51 (1) ◽  
pp. 9-17 ◽  
Author(s):  
H.H. Kariyawasam ◽  
G. Rotiroti ◽  
D.S. Robinson

2013 ◽  
Vol 51 (1) ◽  
pp. 9-17
Author(s):  
H.H. Kariyawasam ◽  
G. Rotiroti ◽  
D.S. Robinson

Sublingual immunotherapy (SLIT) is now an established treatment for allergic rhinitis. Whilst several systematic reviews have now confirmed clinical efficacy and safety, recent analysis also confirms that therapeutic benefit persists for several years after the com- pletion of SLIT. Such findings, along with the obvious ease of administration of sublingual preparations, have clearly promoted SLIT as an attractive option for treatment of allergic rhinitis resistant to medical treatment. This article reviews the development, efficacy and safety of SLIT in allergic rhinitis and the current indications for its use.


2013 ◽  
Vol 149 (2_suppl) ◽  
pp. P258-P258
Author(s):  
Jae-Min Shin ◽  
Il-Ho Park ◽  
Heung-Man Lee

Sign in / Sign up

Export Citation Format

Share Document